Actively Recruiting
Prognostic Markers for a Better Follow-up in Head and Neck Cancer.
Led by Karolinska Institutet · Updated on 2024-03-05
20
Participants Needed
1
Research Sites
641 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To identify tumor specific DNA mutations and aberrations and to follow these in blood over time to predict treatment response/survival and secondly to correlate presence of these markers in blood to pathological parameters (LVI, Pn, WPOI and margins), radiological findings and to tumor stage.
CONDITIONS
Official Title
Prognostic Markers for a Better Follow-up in Head and Neck Cancer.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient diagnosed with head and neck cancer
- Treatment includes surgery
- Consent to participate
You will not qualify if you...
- No consent
- Age below 18 years
- No surgery
- No tumor material to sample
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Karolinska universitetssjukhuset
Stockholm, Sweden, 17176
Actively Recruiting
Research Team
A
Anders Näsman, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here